Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland

Orphanet Journal of Rare Diseases

Volumn 6, Issue 1, 2011, Pages

  Laitinen, Eeva Maria ^a,b   Vaaralahti, Kirsi ^a,b   Tommiska, Johanna ^a,b   Eklund, Elina ^b   Tervaniemi, Mari ^b   Valanne, Leena ^c   Raivio, Taneli ^a,b  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; FGFR1 PROTEIN, HUMAN; KAL1 PROTEIN, HUMAN; NERVE PROTEIN; SCLEROPROTEIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FINLAND; GENE; GENE MUTATION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INCIDENCE; KALI GENE; KALLMANN SYNDROME; MALE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PUBERTY; GENETICS; HYPOGONADISM; MIDDLE AGED; MUTATION; PATHOLOGY; PEDIGREE; SMELLING DISORDER;

ADOLESCENT; ADULT; DNA MUTATIONAL ANALYSIS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FINLAND; HUMANS; HYPOGONADISM; INCIDENCE; KALLMANN SYNDROME; MALE; MIDDLE AGED; MUTATION; NERVE TISSUE PROTEINS; OLFACTION DISORDERS; PEDIGREE; PHENOTYPE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; YOUNG ADULT;

EID: 79958822377     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-6-41     Document Type: Article

References (47)

1. Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. M Schwanzel-Fukuda D Bick DW Pfaff, Brain Res Mol Brain Res 1989 6 311 326 2687610 (Pubitemid 19283316)
2. Kallmann's syndrome, a neuronal migration defect. A Cariboni R Maggi, Cell Mol Life Sci 2006 63 2512 2526 10.1007/s00018-005-5604-3 16952059 (Pubitemid 44724891)
3. Defective migration of neuroendocrine GnRH cells in human arrhinencephalic conditions. L Teixeira F Guimiot C Dode C Fallet-Bianco RP Millar AL Delezoide JP Hardelin, J Clin Invest 2010 120 3668 3672 10.1172/JCI43699 20940512
4. Reversal of idiopathic hypogonadotropic hypogonadism. T Raivio J Falardeau A Dwyer R Quinton FJ Hayes VA Hughes LW Cole SH Pearce H Lee P Boepple WF Crowley Jr N Pitteloud, N Engl J Med 2007 357 863 873 10.1056/NEJMoa066494 17761590 (Pubitemid 47347320)
5. Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism. T Raivio Y Sidis L Plummer H Chen J Ma A Mukherjee E Jacobson-Dickman R Quinton G Van Vliet H Lavoie VA Hughes A Dwyer FJ Hayes S Xu S Sparks UB Kaiser M Mohammadi N Pitteloud, J Clin Endocrinol Metab 2009 94 4380 4390 10.1210/jc.2009-0179 19820032
6. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. SB Seminara FJ Hayes WF Crowley Jr, Endocr Rev 1998 19 521 539 10.1210/er.19.5.521 9793755 (Pubitemid 28467709)
7. Olfacto-genital dysplasia in the female. JR Jones E Kemmann, Obstet Gynecol Annu 1976 5 443 466 790240
8. Delayed puberty: analysis of a large case series from an academic center. IL Sedlmeyer MR Palmert, J Clin Endocrinol Metab 2002 87 1613 1620 10.1210/jc.87.4.1613 11932291 (Pubitemid 34615247)
9. The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics. LM Oliveira SB Seminara M Beranova FJ Hayes SB Valkenburgh E Schipani EM Costa AC Latronico WF Crowley Jr M Vallejo, J Clin Endocrinol Metab 2001 86 1532 1538 10.1210/jc.86.4.1532 11297579 (Pubitemid 32374899)
10. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. N Pitteloud R Quinton S Pearce T Raivio J Acierno A Dwyer L Plummer V Hughes S Seminara YZ Cheng WP Li G Maccoll AV Eliseenkova SK Olsen OA Ibrahimi FJ Hayes P Boepple JE Hall P Bouloux M Mohammadi W Crowley, J Clin Invest 2007 117 457 463 10.1172/JCI29884 17235395 (Pubitemid 46203974)
11. Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J Falardeau WC Chung A Beenken T Raivio L Plummer Y Sidis EE Jacobson-Dickman AV Eliseenkova J Ma A Dwyer R Quinton S Na JE Hall C Huot N Alois SH Pearce LW Cole V Hughes M Mohammadi P Tsai N Pitteloud, J Clin Invest 2008 118 2822 2831 10.1172/JCI34538 18596921
12. Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. GP Sykiotis L Plummer VA Hughes M Au S Durrani S Nayak-Young AA Dwyer R Quinton JE Hall JF Gusella SB Seminara WF Crowley Jr N Pitteloud, Proc Natl Acad Sci USA 2010 107 15140 15144 10.1073/pnas.1009622107 20696889
13. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. C Dode L Teixeira J Levilliers C Fouveaut P Bouchard ML Kottler J Lespinasse A Lienhardt-Roussie M Mathieu A Moerman G Morgan A Murat JE Toublanc S Wolczynski M Delpech C Petit J Young JP Hardelin, PLoS Genet 2006 2 175 10.1371/journal.pgen.0020175 17054399
14. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. B Franco S Guioli A Pragliola B Incerti B Bardoni R Tonlorenzi R Carrozzo E Maestrini M Pieretti P Taillon-Miller CJ Brown HF Willard C Lawrence MG Persico G Camerino A Ballabio, Nature 1991 353 529 536 10.1038/353529a0 1922361 (Pubitemid 21912544)
15. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. R Legouis JP Hardelin J Levilliers JM Claverie S Compain V Wunderle P Millasseau D Le Paslier D Cohen D Caterina L Bougueleret H Dlemarre-Van Der Wall G Lutfalla J Weissenbach C Petit, Cell 1991 67 423 435 10.1016/0092-8674(91)90193-3 1913827
16. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. C Dode J Levilliers JM Dupont A De Paepe N Le Du N Soussi-Yanicostas RS Coimbra S Delmaghani S Compain-Nouaille F Baverel C Pecheux D Le Tessier C Cruaud M Delpech F Speleman S Vermeulen A Amalfitano Y Bachelot P Bouchard S Cabrol JC Carel H Delemarre-van de Waal B Goulet-Salmon ML Kottler O Richard F Sanchez-Franco R Saura J Young C Petit JP Hardelin, Nat Genet 2003 33 463 465 10.1038/ng1122 12627230 (Pubitemid 36390006)
17. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. N Pitteloud C Zhang D Pignatelli JD Li T Raivio LW Cole L Plummer EE Jacobson-Dickman PL Mellon QY Zhou WF Crowley Jr, Proc Natl Acad Sci USA 2007 104 17447 17452 10.1073/pnas.0707173104 17959774 (Pubitemid 350219858)
18. WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. HG Kim JW Ahn I Kurth R Ullmann HT Kim A Kulharya KS Ha Y Itokawa I Meliciani W Wenzel D Lee G Rosenberger M Ozata DP Bick RJ Sherins T Nagase M Tekin SH Kim CH Kim HH Ropers JF Gusella V Kalscheuer CY Choi LC Layman, Am J Hum Genet 2010 87 465 479 10.1016/j.ajhg.2010.08.018 20887964
19. Reversible kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene. N Pitteloud JS Acierno Jr AU Meysing AA Dwyer FJ Hayes WF Crowley Jr, J Clin Endocrinol Metab 2005 90 1317 1322 15613419 (Pubitemid 40463982)
20. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia. EB Trarbach EM Costa B Versiani M de Castro MT Baptista HM Garmes BB de Mendonca AC Latronico, J Clin Endocrinol Metab 2006 91 4006 4012 10.1210/jc.2005-2793 16882753 (Pubitemid 44536878)
21. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. N Pitteloud JS Acierno Jr A Meysing AV Eliseenkova J Ma OA Ibrahimi DL Metzger FJ Hayes AA Dwyer VA Hughes M Yialamas JE Hall E Grant M Mohammadi WF Crowley Jr, Proc Natl Acad Sci USA 2006 103 6281 6286 10.1073/pnas.0600962103 16606836
22. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. HG Kim I Kurth F Lan I Meliciani W Wenzel SH Eom GB Kang G Rosenberger M Tekin M Ozata DP Bick RJ Sherins SL Walker Y Shi JF Gusella LC Layman, Am J Hum Genet 2008 83 511 519 10.1016/j.ajhg.2008.09.005 18834967
23. CHD7 mutations in patients initially diagnosed with Kallmann syndrome - the clinical overlap with CHARGE syndrome. MC Jongmans CM van Ravenswaaij-Arts N Pitteloud T Ogata N Sato HL Claahsen-van der Grinten K van der Donk S Seminara JE Bergman HG Brunner WF Crowley Jr LH Hoefsloot, Clin Genet 2009 75 65 71 10.1111/j.1399-0004.2008.01107.x 19021638
24. The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism. SD Bianco UB Kaiser, Nat Rev Endocrinol 2009 5 569 576 10.1038/nrendo.2009.177 19707180
25. The recent genetics of hypogonadotrophic hypogonadism - novel insights and new questions. RK Semple AK Topaloglu, Clin Endocrinol (Oxf) 2010 72 427 435 10.1111/j.1365-2265.2009.03687.x
26. Characterization of the human nasal embryonic LHRH factor gene, NELF, and a mutation screening among 65 patients with idiopathic hypogonadotropic hypogonadism (IHH). K Miura JS Acierno Jr SB Seminara, J Hum Genet 2004 49 265 268 10.1007/s10038-004-0137-4 15362570 (Pubitemid 38856018)
27. A case of Kallmann syndrome carrying a missense mutation in alternatively spliced exon 8A encoding the immunoglobulin-like domain IIIb of fibroblast growth factor receptor 1. K Miura S Miura K Yoshiura S Seminara D Hamaguchi N Niikawa H Masuzaki, Hum Reprod 2010 25 1076 1080 10.1093/humrep/deq006 20139426
28. Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker. M Wildeman E van Ophuizen JT den Dunnen PE Taschner, Hum Mutat 2008 29 6 13 10.1002/humu.20654 18000842
29. Cell surface expression of 5-hydroxytryptamine type 3 receptors is promoted by RIC-3. A Cheng NA McDonald CN Connolly, J Biol Chem 2005 280 22502 22507 10.1074/jbc.M414341200 15809299 (Pubitemid 40827907)
30. Human non-synonymous SNPs: server and survey. V Ramensky P Bork S Sunyaev, Nucleic Acids Res 2002 30 3894 3900 10.1093/nar/gkf493 12202775 (Pubitemid 35012462)
31. CHD7 mutation spectrum in 28 Swedish patients diagnosed with CHARGE syndrome. J Wincent E Holmberg K Stromland M Soller L Mirzaei T Djureinovic K Robinson B Anderlid J Schoumans, Clin Genet 2008 74 31 38 10.1111/j.1399-0004. 2008.01014.x 18445044 (Pubitemid 351833816)
32. Detection of CHD7 deletions by MLPA in CHARGE syndrome patients with a less typical phenotype. J Wincent A Schulze J Schoumans, Eur J Med Genet 2009 52 271 272 10.1016/j.ejmg.2009.02.005 19248844
33. The rat osteocalcin fibroblast growth factor (FGF)-responsive element: an okadaic acid-sensitive, FGF-selective transcriptional response motif. EP Newberry JM Boudreaux DA Towler, Mol Endocrinol 1996 10 1029 1040 10.1210/me.10.8.1029 8843419 (Pubitemid 26271321)
34. Updated diagnostic criteria for CHARGE syndrome: a proposal. A Verloes, Am J Med Genet A 2005 133A 306 308 10.1002/ajmg.a.30559 15666308 (Pubitemid 40293397)
35. Impuberism and hypogonadism at induction into military service. Statistical study. M Fromantin J Gineste A Didier J Rouvier, Probl Actuels Endocrinol Nutr 1973 16 179 199 4147392
36. Klinefelter's syndrome in Sardinia. Clinical report of 265 hypogonadic males detected at the time of military check-up. G Filippi, Clin Genet 1986 30 276 284 3791676 (Pubitemid 17176284)
37. A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes. J Sarfati A Guiochon-Mantel P Rondard I Arnulf A Garcia-Pinero S Wolczynski S Brailly-Tabard M Bidet M Ramos-Arroyo M Mathieu A Lienhardt-Roussie G Morgan Z Turki C Bremont J Lespinasse H Du Boullay N Chabbert-Buffet S Jacquemont G Reach N De Talence P Tonella B Conrad F Despert B Delobel T Brue C Bouvattier S Cabrol M Pugeat A Murat P Bouchard JP Hardelin C Dode J Young, J Clin Endocrinol Metab 2010 95 659 669 10.1210/jc.2009-0843 20022991
38. Idiopathic hypogonadotropic hypogonadism in a mother and her monozygotic twins born after a single embryo transfer. EM Laitinen J Tommiska L Dunkel U Sankilampi K Vaaralahti T Raivio, Fertil Steril 2010 93 2074.e13 2074.e16 10.1016/j.fertnstert.2009.11.013
39. Impaired FGF signaling contributes to cleft lip and palate. BM Riley MA Mansilla J Ma S Daack-Hirsch BS Maher LM Raffensperger ET Russo AR Vieira C Dode M Mohammadi ML Marazita JC Murray, Proc Natl Acad Sci USA 2007 104 4512 4517 10.1073/pnas.0607956104 17360555 (Pubitemid 47186256)
40. Kallmann syndrome. C Dode JP Hardelin, Eur J Hum Genet 2009 17 139 146 10.1038/ejhg.2008.206 18985070
41. Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. SK Olsen OA Ibrahimi A Raucci F Zhang AV Eliseenkova A Yayon C Basilico RJ Linhardt J Schlessinger M Mohammadi, Proc Natl Acad Sci USA 2004 101 935 940 10.1073/pnas.0307287101 14732692 (Pubitemid 38160562)
42. The structure and function of vertebrate fibroblast growth factor receptor 1. C Groth M Lardelli, Int J Dev Biol 2002 46 393 400 12141425 (Pubitemid 36841006)
43. Identification of three novel mutations in the KAL1 gene in patients with Kallmann syndrome. D Soderlund P Canto JP Mendez, J Clin Endocrinol Metab 2002 87 2589 2592 10.1210/jc.87.6.2589 12050219 (Pubitemid 34655318)
44. Extended and flexible domain solution structure of the extracellular matrix protein anosmin-1 by X-ray scattering, analytical ultracentrifugation and constrained modelling. Y Hu Z Sun JT Eaton PM Bouloux SJ Perkins, J Mol Biol 2005 350 553 570 10.1016/j.jmb.2005.04.031 15949815 (Pubitemid 40828914)
45. Expanding the Phenotypic Overlap Between CHARGE and Kallmann Syndromes due to CHD7 Mutations. (Abstract #1671). H Feret DM McDonald-McGinn A Santani EH Zackai, Presented at the 60th Annual Meeting of The American Society of Human Genetics, November 3, 2010, Washington, DC
46. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome. AP Abreu EB Trarbach M de Castro EM Frade Costa B Versiani MT Matias Baptista HM Garmes BB Mendonca AC Latronico, J Clin Endocrinol Metab 2008 93 4113 4118 10.1210/jc.2008-0958 18682503
47. Disease gene mapping in isolated human populations: the example of Finland. A de la Chapelle, J Med Genet 1993 30 857 865 10.1136/jmg.30.10.857 8230163